Published in Biomed Res Int on October 18, 2015
The impact of ocular blood flow in glaucoma. Prog Retin Eye Res (2002) 5.76
Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma (2000) 3.65
Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol (2001) 2.84
Comparison of dynamic contour tonometry with goldmann applanation tonometry. Invest Ophthalmol Vis Sci (2004) 1.78
Dynamic contour tonometry: presentation of a new tonometer. J Glaucoma (2005) 1.50
Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension. Clin Ophthalmol (2013) 1.48
Definition of glaucoma: clinical and experimental concepts. Clin Experiment Ophthalmol (2012) 1.43
Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol (2008) 1.21
Ocular pulse amplitude in healthy subjects as measured by dynamic contour tonometry. Arch Ophthalmol (2006) 1.09
The clinical utility of dynamic contour tonometry and ocular pulse amplitude. J Glaucoma (2007) 1.08
IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma. Curr Med Res Opin (2010) 1.02
Ocular pulse amplitude in normal tension and primary open angle glaucoma. J Glaucoma (2008) 0.95
Comparisons of intraocular pressure measurements: Goldmann applanation tonometry, noncontact tonometry, Tono-Pen tonometry, and dynamic contour tonometry. Eye (Lond) (2009) 0.93
Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.91
Short-term effects of topical tafluprost on retinal blood flow in cats. J Ocul Pharmacol Ther (2008) 0.89
Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits. J Ocul Pharmacol Ther (2010) 0.87
[Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe]. J Fr Ophtalmol (1999) 0.85
Correlation between ocular pulse amplitude measured by dynamic contour tonometer and visual field defects. Graefes Arch Clin Exp Ophthalmol (2008) 0.85
Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy. Acta Ophthalmol (2009) 0.85
Factors affecting ocular pulse amplitude in eyes with open angle glaucoma and glaucoma-suspect eyes. Acta Ophthalmol (2010) 0.85
Effects of prostaglandin F(2α) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost. Exp Eye Res (2010) 0.84
Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. Br J Clin Pharmacol (2006) 0.83
Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial. Graefes Arch Clin Exp Ophthalmol (2010) 0.82
Effects of corneal thickness and axial length on intraocular pressure and ocular pulse amplitude before and after cataract surgery. Can J Ophthalmol (2011) 0.79
Improvement in glaucoma patient quality of life by therapy switch to preservative-free timolol/dorzolamide fixed combination. Ophthalmologica (2013) 0.79
Tafluprost for the reduction of interocular pressure in open angle glaucoma and ocular hypertension. Ophthalmol Eye Dis (2011) 0.78
Ocular pulse amplitude in patients with asymmetric primary open-angle glaucoma. Curr Eye Res (2011) 0.78
Intraocular pressure variations: causes and clinical significance. Can J Ophthalmol (2014) 0.78
Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension. Clin Ophthalmol (2010) 0.77